The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity.
about
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesN-glycan alterations are associated with drug resistance in human hepatocellular carcinomaCrystal structure of mammalian alpha1,6-fucosyltransferase, FUT8Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potentialEnzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in CancerNK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer ImmunotherapyFc glycans of therapeutic antibodies as critical quality attributesA perspective on the structure and receptor binding properties of immunoglobulin G FcApproaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cellsIn vitro and in vivo modifications of recombinant and human IgG antibodiesChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesTetraspanins as therapeutic targets in hematological malignancy: a concise reviewTargeted therapy for HM1.24 (CD317) on multiple myeloma cellsGlycotherapy: new advances inspire a reemergence of glycans in medicineUnique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucoseStructural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycansImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaFriend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaHuman antibody-Fc receptor interactions illuminated by crystal structuresThe absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan functionIn vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activityB Cell-Based Seamless Engineering of Antibody Fc DomainsDysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient miceDeletion of core fucosylation on alpha3beta1 integrin down-regulates its functionsGlycoengineering of therapeutic antibodies enhances monocyte/macrophage-mediated phagocytosis and cytotoxicityInterleukin-5 and IL-5 receptor in health and diseasesAssessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to AdalimumabAvian embryos and related cell lines: A convenient platform for recombinant proteins and vaccine production.Characterizing biological products and assessing comparability following manufacturing changes.Glycans - the third revolution in evolution.A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.Expression and glycoengineering of functionally active heteromultimeric IgM in plants.Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems.LC-MS/MS peptide mapping with automated data processing for routine profiling of N-glycans in immunoglobulins.Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.Synthetic antibodies as therapeutics.Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.Correlation index-based responsible-enzyme gene screening (CIRES), a novel DNA microarray-based method for enzyme gene involved in glycan biosynthesis.
P2860
Q21131216-B149FD54-9E7C-4A5A-8A1B-6DCAF3734653Q21245732-A4F52778-1B84-4F8C-B39C-48D4E22BFA10Q24337064-F0B0816D-AD0B-4EF7-B726-F13FFCAC7D27Q26744275-D4755999-1C61-472D-AF77-BA23C6DF2F78Q26748089-EE08C6A8-C1EA-427A-85C1-ADFE01C56182Q26797345-578EB1D9-97CE-442F-83C0-4F440B526DE4Q26799266-0243B598-721C-4F0D-B08F-38F299C916B7Q26827579-981C2AF5-44A9-44DD-978F-886DEB015A72Q26852287-E407AA84-ADCF-40F8-A6F4-31639194950DQ26859713-D6D93A78-9B18-4C54-8DA8-EEC3E5793E7FQ26866236-D092CDB0-FE18-45E2-8AC9-FFBC0FA6E4C4Q27002353-521E6F09-C0F1-4AD3-9CEF-BA9CE80AFDDBQ27026161-164775F6-462C-449B-8BE7-45538F713221Q27027997-45AA2CF4-E8A6-455E-B23D-08834B40F2B6Q27670877-64F59FAD-2FC8-4E81-B17C-65BFCFFF2DA8Q27675205-036AFF9E-AE5D-4AE8-897A-81AF8BDB0875Q28069362-787EC56D-89D8-4E26-BF53-798D69B64B34Q28069952-39E0F10E-DA63-42A3-9519-EF398C7ADFA7Q28072320-FCD5651E-D63B-4ADA-B081-4F8B91C5114CQ28252414-778EE706-348D-4F8D-9127-E2ADDB54BFECQ28510399-3EAA6DCE-A1D3-4413-88EB-BF070847BC61Q28547176-9E5D783E-3B9D-4457-ACD7-8C62AAB4AD2EQ28554659-D2DE1CCE-7330-404B-B460-413E101B0114Q28585434-961B5B5D-2C9A-4BCB-957E-C0C660B9B132Q28593539-08B742D3-334E-477D-A948-D6059D5B8D90Q28658712-ABCADE00-AEE0-430E-9C08-3CBBB885745CQ28730921-BAF8FE53-71C1-4459-86B2-5DD72392ED25Q28831404-0CC8F67D-A743-49FC-8FF0-868C0823D7F3Q30234979-DC187D3B-AA78-4AF7-8ECD-86AC96EFB1C4Q30344134-93CF3FD4-4F72-4774-AA51-D4C89C906397Q30363360-4C8A2BE1-EC48-45DF-A5CC-71704D96DF85Q30368704-E5FF0ECC-333F-4B35-AF7A-33AD6B4803D1Q30412932-47D989DE-06C3-4B45-BFF5-CF847F395721Q30467353-2AD3DE92-2D88-49B7-87B9-4C99006898F1Q30784999-F557DDAE-684C-4A78-9BAD-1D02C8BFAD20Q33224048-71F3990B-E6CD-46BC-B66B-311F2876A3D8Q33234976-9AC6B30E-F18C-4208-A705-407A0C5D773FQ33265617-839872AC-5B40-41BD-B79E-F14022270A11Q33292639-8722DE0D-D3D4-484A-A2BA-2F79F19733C6Q33307532-FA69D3F4-25DD-47E2-9128-466D2FFD832C
P2860
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The absence of fucose but not ...... pendent cellular cytotoxicity.
@en
type
label
The absence of fucose but not ...... pendent cellular cytotoxicity.
@en
prefLabel
The absence of fucose but not ...... pendent cellular cytotoxicity.
@en
P2093
P921
P356
P1476
The absence of fucose but not ...... pendent cellular cytotoxicity.
@en
P2093
Emi Shoji-Hosaka
Hideharu Anazawa
Kazuhisa Uchida
Kazuyasu Nakamura
Kenya Shitara
Mikiko Sakurada
Mitsuo Satoh
Motoo Yamasaki
Naoko Yamane
Nobuo Hanai
P304
P356
10.1074/JBC.M210665200
P407
P577
2002-11-08T00:00:00Z